About Bradley Margus
Bradley Margus is a board chair at MindImmune Therapeutics.
Experience
This experience comes from SEC filings. The years are when the filings name Bradley Margus in the role, so the role may have started earlier or lasted longer.
MindImmune Therapeutics, Inc.
Board Chair
2025 – 2026 · Kingston, RI
Develops immune-targeting drugs for people with Alzheimer's and other neurodegenerative diseases.
Key Colleagues at Startups
The people Bradley Margus works with at each company, as listed on that company's latest Form D.
MindImmune Therapeutics, Inc. · Form D/A, Mar 5, 2026
